LAVA Therapeutics N.V. (LVTX)
NASDAQ: LVTX · Real-Time Price · USD
0.954
+0.042 (4.63%)
Feb 11, 2025, 11:06 AM EST - Market open
LAVA Therapeutics Market Cap
LAVA Therapeutics has a market cap or net worth of $24.92 million as of February 11, 2025. Its market cap has decreased by -58.25% in one year.
Market Cap
24.92M
Enterprise Value
-48.61M
1-Year Change
-58.25%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on March 25, 2021, LAVA Therapeutics's market cap has increased from $23.26M to $24.92M, an increase of 7.15%. That is a compound annual growth rate of 1.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2025 | 24.48M | -4.12% |
| Dec 31, 2024 | 25.53M | -39.64% |
| Dec 29, 2023 | 42.30M | -54.03% |
| Dec 30, 2022 | 92.01M | -35.10% |
| Dec 31, 2021 | 141.77M | 509.47% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 790.86B |
| UnitedHealth Group | 485.02B |
| Novo Nordisk | 386.78B |
| Johnson & Johnson | 368.66B |
| AbbVie | 336.82B |
| Abbott Laboratories | 223.87B |
| AstraZeneca | 223.06B |
| Merck & Co. | 220.79B |